The recent instability in global supply have highlighted the necessity of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes nations to significant vulnerabilities, including transportation delays, cost fluctuations, and even political threats. Transitioning towards domestic production of Ivermectin offers a m